📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Attgeno

1.1 - Company Overview

Attgeno Logo

Attgeno

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical treatments for acute life-threatening conditions, including Supernitro, an intravenous drug for acute pulmonary hypertension that delivers nitric oxide directly to the lungs to reduce pulmonary blood pressure with minimal systemic effects.

Products and services

  • Supernitro: Intravenous pharmaceutical engineered to treat acute pulmonary hypertension by delivering nitric oxide directly to the lungs, reducing pulmonary blood pressure with minimal systemic effects.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Attgeno

Tarilian Laser Technologies Logo

Tarilian Laser Technologies

HQ: United Kingdom Website
  • Description: Provider of medical technology pioneering an innovative breakthrough in blood pressure monitoring through an unobtrusive wrist-worn wearable device.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tarilian Laser Technologies company profile →
NitroMed Logo

NitroMed

HQ: United States Website
  • Description: Provider of proprietary nitric oxide-based pharmaceuticals, leveraging substantial expertise and intellectual property in nitric oxide drug development. The company discovers, develops, and seeks to commercialize therapies based on the therapeutic benefits of nitric oxide and is conducting a late-stage confirmatory trial of its lead nitric oxide-enhancing drug, BiDil.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NitroMed company profile →
ev3 Logo

ev3

HQ: United States Website
  • Description: Provider of technology solutions for specialists treating a wide range of vascular diseases and disorders, serving the peripheral vascular and neurovascular markets with a comprehensive portfolio of treatment options, including primary interventional technologies such as peripheral angioplasty.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ev3 company profile →
Baylis Medical Logo

Baylis Medical

HQ: Canada Website
  • Description: Provider of high-technology cardiology, endovascular, and oncology products, specializing in RF transseptal access and puncture systems that create controlled perforations in cardiac and vascular tissues. Products include NRG RF Transseptal Kit and Needle, SupraCross RF Transseptal Solution, VersaCross steerable access solutions, and SureFlex steerable guiding sheaths.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Baylis Medical company profile →
CinCor Pharma Logo

CinCor Pharma

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, metabolic, and kidney diseases, advancing promising clinical candidates toward marketing approval, including CIN-107, a novel aldosterone synthase inhibitor.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CinCor Pharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Attgeno

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Attgeno

2.2 - Growth funds investing in similar companies to Attgeno

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Attgeno

4.2 - Public trading comparable groups for Attgeno

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Attgeno

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Attgeno

What does Attgeno do?

Attgeno is a provider of pharmaceutical treatments for acute life-threatening conditions, including Supernitro, an intravenous drug for acute pulmonary hypertension that delivers nitric oxide directly to the lungs to reduce pulmonary blood pressure with minimal systemic effects.

Who are Attgeno's competitors?

Attgeno's competitors and similar companies include Tarilian Laser Technologies, NitroMed, ev3, Baylis Medical, and CinCor Pharma.

Where is Attgeno headquartered?

Attgeno is headquartered in Sweden.

How many employees does Attgeno have?

Attgeno has 1,000 employees 🔒.

When was Attgeno founded?

Attgeno was founded in 2010 🔒.

What sector and industry vertical is Attgeno in?

Attgeno is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Attgeno

Who are the top strategic acquirers in Attgeno's sector and industry

Top strategic M&A buyers and acquirers in Attgeno's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Attgeno?

Top strategic M&A buyers groups and sectors for Attgeno include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Attgeno's sector and industry vertical

Which are the top PE firms investing in Attgeno's sector and industry vertical?

Top PE firms investing in Attgeno's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Attgeno's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Attgeno's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Attgeno's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Attgeno include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Attgeno's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Attgeno?

The key public trading comparables and valuation benchmarks for Attgeno include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Attgeno for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Attgeno with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Attgeno's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Attgeno with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Attgeno's' sector and industry vertical?

Access recent funding rounds and capital raises in Attgeno's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Attgeno